164 related articles for article (PubMed ID: 38229045)
21. Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece.
Haidopoulos D; Pergialiotis V; Aggelou K; Thomakos N; Alexakis N; Stamatakis E; Rodolakis A
Surg Oncol; 2022 Mar; 40():101702. PubMed ID: 35065392
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in pelvic exenteration for gynecological malignancies.
Baiocchi G; Guimaraes GC; Rosa Oliveira RA; Kumagai LY; Faloppa CC; Aguiar S; Begnami MD; Soares FA; Lopes A
Eur J Surg Oncol; 2012 Oct; 38(10):948-54. PubMed ID: 22818842
[TBL] [Abstract][Full Text] [Related]
23. A surgeon's help with the management of bowel problems related to gynecology is truly needed - comparison of two periods spanning 24 years.
Hsu TC; Huang TM; Yang YC
Taiwan J Obstet Gynecol; 2012 Dec; 51(4):612-5. PubMed ID: 23276566
[TBL] [Abstract][Full Text] [Related]
24. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
25. Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies.
Fotopoulou C; Neumann U; Kraetschell R; Schefold JC; Weidemann H; Lichtenegger W; Sehouli J
J Surg Oncol; 2010 May; 101(6):507-12. PubMed ID: 20401918
[TBL] [Abstract][Full Text] [Related]
26. Influence of tumor size on outcomes following pelvic exenteration.
Smith B; Jones EL; Kitano M; Gleisner AL; Lyell NJ; Cheng G; McCarter MD; Abdel-Misih S; Backes FJ
Gynecol Oncol; 2017 Nov; 147(2):345-350. PubMed ID: 28822555
[TBL] [Abstract][Full Text] [Related]
27. Disease-free survival after robotic-assisted laparoscopic total pelvic exenteration for recurrent cervical adenocarcinoma: A case report.
Yang Q; Tang J; Xiao L
Medicine (Baltimore); 2018 Jul; 97(30):e11611. PubMed ID: 30045297
[TBL] [Abstract][Full Text] [Related]
28. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA.
Berek JS; Howe C; Lagasse LD; Hacker NF
Gynecol Oncol; 2005 Oct; 99(1):153-9. PubMed ID: 16054678
[TBL] [Abstract][Full Text] [Related]
29. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
[TBL] [Abstract][Full Text] [Related]
30. [Results of laparoscopic pelvic exenterations].
Sanzharov AE; Gallyamov EA; Sergeev VP; Biktimirov RG; Aminova LN; Kochkin AD; Meshchankin IV; Agapov MA; Gololobov GY
Khirurgiia (Mosk); 2022; (7):45-57. PubMed ID: 35775844
[TBL] [Abstract][Full Text] [Related]
31. Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies.
Tortorella L; Casarin J; Mara KC; Weaver AL; Multinu F; Glaser GE; Cliby WA; Scambia G; Mariani A; Kumar A
Gynecol Oncol; 2019 Jan; 152(1):151-156. PubMed ID: 30414740
[TBL] [Abstract][Full Text] [Related]
32. Laparoscopic pelvic exenteration for advanced pelvic cancers: a review of 16 cases.
Puntambekar S; Kudchadkar RJ; Gurjar AM; Sathe RM; Chaudhari YC; Agarwal GA; Rayate NV
Gynecol Oncol; 2006 Sep; 102(3):513-6. PubMed ID: 16510172
[TBL] [Abstract][Full Text] [Related]
33. Utilization and perioperative outcome of minimally invasive pelvic exenteration in gynecologic malignancies: A national study in the United States.
Matsuo K; Matsuzaki S; Mandelbaum RS; Kanao H; Chang EJ; Klar M; Roman LD; Wright JD
Gynecol Oncol; 2021 Apr; 161(1):39-45. PubMed ID: 33402282
[TBL] [Abstract][Full Text] [Related]
34. Short- and long-term outcomes of laparoscopic versus open pelvic exenteration for locally advanced rectal cancer: a single-center propensity score matching analysis.
Tang J; Liu J; Du B; Zhang J; Zheng L; Wang X; Wan Y
Tech Coloproctol; 2023 Jan; 27(1):43-52. PubMed ID: 36194310
[TBL] [Abstract][Full Text] [Related]
35. Pelvic exenterations for primary rectal cancer: Analysis from a 10-year national prospective database.
Pellino G; Biondo S; Codina Cazador A; Enríquez-Navascues JM; Espín-Basany E; Roig-Vila JV; García-Granero E;
World J Gastroenterol; 2018 Dec; 24(45):5144-5153. PubMed ID: 30568391
[TBL] [Abstract][Full Text] [Related]
36. [Robot-assisted laparoscopy in the management of recurrent pelvic cancer].
Jauffret C; Lambaudie E; Bannier M; Buttarelli M; Houvenaeghel G
Gynecol Obstet Fertil; 2011 Dec; 39(12):674-80. PubMed ID: 21871833
[TBL] [Abstract][Full Text] [Related]
37. Pelvic exenteration as ultimate ratio for gynecologic cancers: single-center analyses of 37 cases.
de Gregorio N; de Gregorio A; Ebner F; Friedl TWP; Huober J; Hefty R; Wittau M; Janni W; Widschwendter P
Arch Gynecol Obstet; 2019 Jul; 300(1):161-168. PubMed ID: 31011878
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer.
Sardain H; Lavoué V; Laviolle B; Henno S; Foucher F; Levêque J
Int J Gynecol Cancer; 2014 Nov; 24(9):1679-85. PubMed ID: 25254565
[TBL] [Abstract][Full Text] [Related]
39. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
40. [Pelvic exenterations for gynaecological cancer--a 10 year institutional review].
Pinelo S; Petiz A; Domingues C; Lopes C; Alves A; Fael R
Acta Med Port; 2006; 19(2):99-104. PubMed ID: 17187709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
